CHILDREN WITH HCV INFECTION SHOW HIGH SUSTAINED VIROLOGIC RESPONSE RATES ON PEGINTERFERON ALFA-2B PLUS RIBAVIRIN TREATMENT

被引：0

作者：

Wirth, Stefan ^{[1
]}

Ribes-Koninckx, Carmen ^{[2
]}

Bortolotti, Flavia ^{[3
]}

Zancan, Lucia ^{[3
]}

Jara, Paloma ^{[4
]}

Shelton, Mark M. ^{[5
]}

Kerkar, Nanda ^{[6
]}

Galoppo, Cristina ^{[7
]}

Rodriguez-Baez, Norberto ^{[8
]}

Ciocca, Mirta ^{[9
]}

Lachaux, Alain ^{[10
]}

Lacaille, Florence ^{[11
]}

Lang, Thomas ^{[12
]}

Kullmer, Ulrike ^{[13
]}

Huber, Wolf Dietrich ^{[14
]}

Gonzalez, Teresita ^{[15
]}

Pollack, Henry ^{[16
]}

Alonso, Estella M. ^{[17
]}

Broue, Pierre ^{[18
]}

Ramakrishna, Jyoti ^{[19
]}

Neigut, Deborah ^{[20
]}

Del Valle-Segarra, Antonio I. ^{[21
]}

Hunter, Bessie A. ^{[22
]}

Brass, Clifford A. ^{[23
]}

Noviello, Stephanie ^{[23
]}

Sniukiene, Vilma ^{[23
]}

Harvey, Joann ^{[23
]}

Albrecht, Janice K. ^{[23
]}

机构：

[1] Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Wuppertal, Germany

[2] Hosp Infantil La Fe, Valencia, Spain

[3] Azienda Osped Padova, Padua, Italy

[4] Hosp Univ Infantil La Paz, Madrid, Spain

[5] Cook Childrens Hlth Care Network, Ft Worth, TX USA

[6] Mt Sinai Med Ctr, New York, NY 10029 USA

[7] Hosp Gen Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina

[8] Childrens Med Ctr, Dallas, TX 75235 USA

[9] Hosp Aleman, Buenos Aires, DF, Argentina

[10] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France

[11] Hop Necker Enfants Malad, APH Paris, Paris, France

[12] Klinikum Starnberg, Starnberg, Germany

[13] Johannes Gutenberg Univ Mainz, Univ Klin & Poliklin Kinder & Jugendliche JG, Mainz, Germany

[14] Univ Clin Pediat, Vienna, Austria

[15] Hosp Ninos Sor Maria Ludov La Plata, La Plata, Buenos Aires, Argentina

[16] NYU, New York, NY USA

[17] Childrens Mem Hosp, Chicago, IL 60614 USA

[18] CHU Toulouse Hepatol Pediat, Hop Enfants, Toulouse, France

[19] Univ Massachusetts Mem Hlth Care, Worcester, MA USA

[20] Christus Santa Rosa Childrens Hosp, San Antonio, TX USA

[21] Univ Pediat Hosp, San Juan, PR USA

[22] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile

[23] Schering Plough Res Inst, Kenilworth, NJ USA

来源：

HEPATOLOGY | 2008年 / 48卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

187

引用

页码：392A / 393A

页数：2

共 50 条

[1] High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
Wirth, Stefan
Ribes-Koninckx, Carmen
Angeles Calzado, Maria
Bortolotti, Flavia
Zancan, Lucia
Jara, Paloma
Shelton, Mark
Kerkar, Nanda
Galoppo, Marcela
Pedreira, Alejandra
Rodriguez-Baez, Norberto
Ciocca, Mirta
Lachaux, Alain
Lacaille, Florence
Lang, Thomas
Kullmer, Ulrike
Huber, Wolf Dietrich
Gonzalez, Teresita
Pollack, Henry
Alonso, Estella
Broue, Pierre
Ramakrishna, Jyoti
Neigut, Deborah
del Valle-Segarra, Antonio
Hunter, Bessie
Goodman, Zachery
Xu, Christine R.
Zheng, Hanzhe
Noviello, Stephanie
Sniukiene, Vilma
Brass, Clifford
Albrecht, Janice K.
JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 501 - 507
[2] LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION
Teuber, G.
Mauss, S.
Hueppe, D.
Zehnter, E.
Manns, M. P.
Dahhan, T.
Meyer, U.
Witthoeft, T.
Moeller, B.
Dikopoulos, N.
Brack, J.
Hartmann, D.
Dreher, B.
Bilzer, M.
JOURNAL OF HEPATOLOGY, 2013, 58 : S376 - S376
[3] Thyroid Dysfunction Triggered by Peginterferon Alfa-2B/Ribavirin Treatment of Chronic HCV Genotype 1 Infection Favors Sustained Virologic Response (SVR) by Reducing
Mauss, Stefan
Hueppe, Dietrich
Zehnter, Elmar
Manns, Michael P.
Teuber, Gerlinde
Dahhan, Tarek
Meyer, Ulrike
Witthoeft, Thomas
Moeller, Bernd
Dikopoulos, Nektarios
Brack, Jochen
Dach, Kristina
Stade, Barbara
Bilzer, Manfred
GASTROENTEROLOGY, 2012, 142 (05) : S956 - S956
[4] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
Davis, GL
Wong, JB
McHutchison, JG
Manns, MP
Harvey, J
Albrecht, J
HEPATOLOGY, 2003, 38 (03) : 645 - 652
[5] FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Vierling, J. M.
Lawitz, E. J.
Poordad, F.
Sulkowski, M. S.
Bourliere, M.
Buti, M.
Cooper, C.
Galati, J. S.
Albrecht, J. K.
Boparai, N.
Brass, C. A.
Burroughs, M.
Sniukiene, V.
Bruno, S.
JOURNAL OF HEPATOLOGY, 2011, 54 : S197 - S197
[6] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
Laguno, M
Murillas, J
Blanco, JL
Martínez, E
Miquel, R
Sánchez-Tapias, JM
Bargallo, X
García-Criado, A
de Lazzari, E
Larrousse, M
León, A
Loncá, M
Milinkovic, A
Gatell, JM
Mallolas, J
AIDS, 2004, 18 (13) : F27 - F36
[7] Sustained virologic response and relapse rates with peginterferon alfa-2b plus ribavirin in clinical trials are comparable to those in community-based studies
Manns, Michael P.
Hueppe, Dietrich
Marotta, Paul
Mauss, Stefan
Zehnter, Elmar
Jacobson, Ira M.
Kambili, Chrispin
GASTROENTEROLOGY, 2008, 134 (04) : A830 - A830
[8] Clearance of HCV at 5 year follow-up for peginterferon alfa-2b ± ribavirin is predicted by sustained virologic response at 24 weeks post treatment
Lindsay, Karen
Manns, Michael P.
Gordon, Stuart C.
Pockros, Paul
Haussinger, Dieter
Hadziyannis, Stephanos J.
Schmidt, Warren N.
Jacobson, Ira M.
Barcena, Rafael
Schiff, Eugene
Shaikh, Obaid S.
Bacon, Bruce R.
Marcellin, Patrick
Smith, Coleman I.
McHutchison, John G.
Deng, Weipeng
Pedicone, Lisa D.
Albrecht, Janice
GASTROENTEROLOGY, 2008, 134 (04) : A772 - A772
[9] Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaiVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1
Manns, Michael P.
Poordad, Fred
Bacon, Bruce R.
Bruno, Savino
Esteban, Rafael
Silva, Marcelo O.
Buti, Maria
Burroughs, Margaret
Sniukiene, Vilma
Boparai, Navdeep
Brass, Cliflord A.
Albrecht, Janice K.
Bronowicki, Jean-Pierre
GASTROENTEROLOGY, 2011, 140 (05) : S942 - S942
[10] Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C
Wirth, S
Pieper-Boustani, H
Lang, T
Ballauff, A
Kullmer, U
Gerner, P
Wintermeyer, P
Jenke, A
HEPATOLOGY, 2005, 41 (05) : 1013 - 1018

← 1 2 3 4 5 →